Drugs (psychoactive) - World Health Organization (WHO)
2023年8月8日 · About 296 million people aged 15-64 had used psychoactive drugs in 2021 and about 39.5 million people are estimated to be affected by drug use disorders (harmful pattern of drug use or drug dependence). It is estimated that about 0.6 million death annually are attributable to drug use with about 420 000 male and 160 000 female deaths.
WHO Drug Information
Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers, consumer bodies, and pharmaceutical manufacturers and focuses on topics impacting the safety, efficacy and quality of medicines, medical products, herbals and biomedicines.
Medicines - World Health Organization (WHO)
2024年11月26日 · The first is regulatory issues, which can affect how medicines are bought to market, create lag times and cause the supply of medicines in some areas of the globe to be delayed long after they are available elsewhere. High prices, misuse of drugs and poor or unreliable drug quality contribute to this issue.
Over 3 million annual deaths due to alcohol and drug use, majority ...
2024年6月25日 · A new report from the World Health Organization (WHO) highlights that 2.6 million deaths per year were attributable to alcohol consumption, accounting for 4.7% of all deaths, and 0.6 million deaths to psychoactive drug use. Notably, 2 million of alcohol and 0.4 million of drug-attributable deaths were among men.
Defined Daily Dose (DDD) - World Health Organization (WHO)
Drug utilization data presented in DDDs give a rough estimate of consumption and not an exact picture of actual use. DDDs provide a fixed unit of measurement independent of price, currencies, package size and strength enabling the researcher to assess trends in drug utilization and to perform comparisons between population groups.
6. TB research and innovation - World Health Organization (WHO)
One drug that was approved by the United States (US) Food and Drug Administration under the limited population pathway for antibacterial and antifungal drugs. This is pretomanid, which is part of the 6-month regimen for MDR/RR-TB and pre-XDR-TB recommended by WHO since 2022 (14). Its safety and efficacy in the treatment of drug-resistant TB ...
56th meeting of the WHO International Working Group for Drug …
The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD) as a measuring unit have become the gold standard for international drug utilization research.The ATC/DDD system is a tool for exchanging and comparing data on drug use at international, national or local levels.
How to set up a Drug Utilization Study - World Health …
Click here to visualize the example. All DDDs assigned are available here; The yellow part of the list represents the basic elements of the drug list/product registry with ATC and DDD information added at the package level (only two packages included, but multiplied in this list of drug utilization data where each line represents a hospital department).
Medication Without Harm - World Health Organization (WHO)
2022年9月17日 · The 5 Moments for Medication Safety is a patient engagement tool developed to support the implementation of the third WHO Global Patient Safety Challenge: Medication Without Harm.
Anatomical Therapeutic Chemical (ATC) Classification
Medicinal substances frequently have several ATC codes for various routes of administration with different therapeutic uses, for example products that contain prednisolone as a single ingredient have eight different ATC codes according to the indication (systemic and …